Successful clinical trial reveals safety and effectiveness of breast cancer drug
Many breast cancer patients buy Tamoxifen to slow the progression of breast cancer, and acquiring this product from a Canadian internet pharmacy can help them save money.
Many breast cancer patients buy Tamoxifen to slow the progression of breast cancer, and acquiring this product from a Canadian internet pharmacy can help them save money. They may soon have another option in the form of a drug called exemestane, which recently met with positive results in a phase III clinical trial conducted at the University of Buffalo.
Scientists published a paper in the New England Journal of Medicine about the study, which involved more than 4,500 women throughout the U.S., Canada, Spain and France.
The team discovered that exemestane appeared to be both safe and effective, causing no adverse side effects among the patients to whom it was given. The drug could reduce the risk of developing breast cancer and work for numerous forms of the disease, compared to Tamoxifen and raloxifene, which tend to be more selective.
"These are very exciting results. There were very few side effects and limited adverse events," said lead investigator Jean Wactawski-Wende. "We expect exemestane will be generally acceptable for use in women at high risk who want to reduce their chances of developing breast cancer in the first place."
|
